Skip to content

Clinical trials

Phase 3 Aspergillosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Aspergillosis Phase: Phase 3 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20083
20121
20141
20181
20191
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
National Cancer Institute (NCI)3
Post Graduate Institute of Medical Education and Research, Chandigarh3
Astellas Pharma Inc2
Pfizer2
Asahi Kasei Therapeutics Corporation1
Janssen Pharmaceutical K.K.1
National Institute of Allergy and Infectious Diseases (NIAID)1
Singapore General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Aspergillosis17
Mycoses6
Candidiasis5
Cryptococcosis4
Fungemia3
Invasive Fungal Infections3
Neutropenia2
Acquired Immunodeficiency Syndrome1
Blastomycosis1
Candidemia1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.